fashion -WSS

fashion

author：hotspot 2025-09-27 23:52:17 - browse：39

Five elderly people have been blinded in one eye by a severe side effect after receiving injections of a newly approved treatment for eye disease from Apellis Pharmaceuticals. The frequency of this side effect — a severe type of eye inflammation — is low but its cause remains unknown.

The new safety information related to the Apellis drug, called Syfovre, was presented Saturday by a committee of eye disease experts at the annual meeting of the American Society of Retinal Specialists (ASRS).

Apellis cooperated with the ASRS analysis but the company also announced its own internal review Saturday that found fewer cases of retinal occlusive vasculitis, a type of severe eye inflammation that blocks blood flow to the retina and can result in blindness. The rate of retinal occlusive vasculitis reported remains “very rare,” the company said, adding that there is no evidence linking the drug product or its manufacturing to the severe side effect.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： US intelligence assessment says Iran not currently developing nuclear weapons

focus

hotspot

WSS

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

The health care issue Democrats can’t solve: hospital reform

Key Senate panel to consider PBM, drug pricing reform package

Rare Northern Lights show in US this week: Where and how to see it

Drinking water from half of US faucets contains PFAS: Study

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

knowledge

fashion

explore

How to save PrEP access — and even expand it

After Sarepta trial failure, Duchenne families brace for more debate

Trump demands the U.S. pay no more for drugs than other countries … again

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Supreme Court strikes down use of affirmative action

Gene therapy’s promise and the high cost of hope

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Malaria cases in Florida and Texas: Here’s what you need to know

How neuroscience research could help beat back brain cancer

focus

Brain injuries and the importance of a second opinion

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Rare Northern Lights show in US this week: Where and how to see it

Another man arrested in connection with shooting at Kansas nightclub

Lung cancer screening guidelines updated for cigarette smokers

focus

focus

hotspot

focus